prevention focused cardiologist; platelet scientist; thrombosis & vascular medicine specialist; proud husband & father of fantastic girls; @NYUCVDPrevent
Joined March 2018
- Tweets628
- Following286
- Followers960
- Likes1.2K
Pinned Tweet
Finally! A circulating platelet genetic signature (PRESS)🔥that predicts platelet hyperreactivity and increased cardiovascular risk. Collaborative science is awesome!! @TessaJBarrett @NSmilowitzMD @NYUCVDPrevent @NYULHCVRC
nature.com/articles/s41467-0…
Dr. Jeffrey Berger retweeted
Fellowship Opportunity! Accepting applications for our 1-year fellowship in preventive #cardiology.
The fellowship offers specialized training in primary & secondary #CVD prevention, including advanced lipid disorders, hypertension, thrombosis & more.⤵️
bit.ly/3NYDvLc
Dr. Sean Heffron of @NYUCVDPrevent, in collaboration with @American_Heart, is highlighting why talking about weight can be challenging - but is essential to empowering patients and protecting long-term #HeartHealth through effective weight management heart.org/en/news/2026/08/18…
Dr. Jeffrey Berger retweeted
What if talking about your weight with your doctor could be the first step toward better health?
Our Center’s preventive cardiologist, Dr. Sean Heffron, says it’s a crucial conversation: “Every organ system is adversely affected by excess body weight.”⤵️
heart.org/en/news/2026/08/18…
Great collaboration between @Perlmutter_CC and @NYUCVDPrevent demonstrating divergent Effects of #GnRH Agonist & GnRH Antagonist Treatment on #Platelet Activity and Transcriptome | JACC: CardioOncology @JACCJournals @nyulangone jacc.org/doi/10.1016/j.jacca…
Dr. Jeffrey Berger retweeted
In the prospective POPPY study, @nyulangone researchers linked first-trimester platelet hyperreactivity to nearly fourfold higher odds of ischemic placental disease—and to higher platelet aggregation despite taking aspirin 81 mg daily.
Read more ⤵️ bit.ly/4aQHy7t
Dr. Jeffrey Berger retweeted
Proud to be named by @healthcentral as one of its 10 Centers of Excellence in Cardiovascular Care.
The report recognizes our Center's multidisciplinary approach & specialized programs, including Cardio-Rheumatology and Postpartum Cardiovascular Health.
healthcentral.com/condition/…
Dr. Jeffrey Berger retweeted
Congratulations to Dr. Edward A. Fisher on winning the prestigious 2026 Leducq Foundation award! Dr. Fisher will co-lead a $9M global network studying how #obesity & weight cycling impacts #CVD risk.
➡️bit.ly/4v4NTE9
@edwardfisher20 @PlateletDoc @ChiaraGiannare1
Congratulations to Edward A. Fisher, MD, PhD, on receiving a 2026 Leducq Foundation International Network of Excellence award to co-lead a global research network studying how obesity and weight cycling affect cardiovascular disease risk.
Read more ➡️ bit.ly/4v4NTE9
Dr. Jeffrey Berger retweeted
Congrats to Dr. Mark Steuerwald our preventive cardiology fellow, on passing the lipid boards (@nationallipid).
Becoming a Diplomate of the American Board of Clinical Lipidology is the highest benchmark of professional competency in Clinical Lipidology.
Well deserved! 👏
Dr. Jeffrey Berger retweeted
📣New in AJPC: AHA #Lipoprotein(a) Discovery Project
Congrats to Dr. Howard Weintraub and colleagues on this publication! This 3 year project was instrumental in developing foundational clinician & patient education resources to advance #LPA awareness.
sciencedirect.com/science/ar…
Incredible collaboration between #Cardiology and #Obstetrics demonstrating #Platelet hyperreactivity in #pregnancy and risk of ischemic placental disease: The POPPY Study #plateletlab obgyn.onlinelibrary.wiley.co… @ACOGPregnancy @Pregnancy @NYULH_DeptofMed @nyulangone @NYUCVDPrevent
Being presented by #MFM specialist Dr Christina Penfield - an outstanding physician scientist - at @MySMFM - exciting ongoing work connecting the link between platelets and adverse pregnancy outcomes #preeclampsia #HDP
Dr. Jeffrey Berger retweeted
🗞️Now on @JCI_insight! Monocyte #platelet aggregates (MPA) emerges as a biomarker of thromboinflammation. TIPS, a platelet RNA signature, captures thromboinflammation and holds promise for cardiovascular risk stratification and therapeutic targeting.
insight.jci.org/articles/vie…
Finally - a #platelet genetic signature (TIPS)🔥of #thromboinflammation and increased cardiovascular risk. Collaborative science is awesome!! insight.jci.org/articles/vie…
@TessaJBarrett
@garshick
@NYUCVDPrevent
@NYULHCVRC @JCI_insight
Dr. Jeffrey Berger retweeted
Why are #PCSK9 inhibitors still underutilized?
Join leading lipid expert Dr. James Underberg to explore how PCSK9 inhibitors can help patients with ASCVD, HeFH, & HoFH #knowFH achieve LDL-C goals that have remained out of reach with standard therapies.
🔗nyulmc.org/cvriskcme
Dr. Jeffrey Berger retweeted
📢 Don’t miss this CME! Join us on Dec 4 (NYC/online), to hear #CKM health expert Chiadi Ndumele, MD, PhD, MHS, discuss optimal strategies for enhancing cardiovascular-kidney-metabolic health.
Save your seat: nyulmc.org/cvriskcme
Jointly provided @nyugrossman & @NewYorkACP
Dr. Jeffrey Berger retweeted
📰Now available via @ScienceAdvances!
Our investigators and colleagues report on work that identifies the mechanism of platelet-induced mitochondrial dysfunction in myocardial dysfunction
@plateletdoc
➡️science.org/doi/epdf/10.1126…
Thank you @ScienceAdvances for publishing our collaborative effort demonstrating how #Platelets induce vascular dysfunction in myocardial infarction @JoshuaBeckmanMD @TessaJBarrett @smilowitz @NYUCVDPrevent @NYULHCVRC science.org/doi/10.1126/scia…
Dr. Jeffrey Berger retweeted
Personalized #CVD prevention is on the horizon!
Today at #AHA25 (1:59-2:04pm), Dr. Carine Hamo will share details about PROSPER, a circulating plasma protein signature that identifies heightened platelet activity & predicts CVD risk.
Pop Sci Zone
Mod Dig Poster 10
AI.MDP.23
Dr. Jeffrey Berger retweeted
How does aggressive #lipid lowering affect vascular endothelium in #diabetic vs healthy individuals?
➡️Sun, 11/9 (11:50-11:55 AM) at #AHA25
Stop by moderated digital poster 13 (PL.MDP.09) to hear findings from the Cardiometabolic Health Strategically Focused Research Network.
